Patents by Inventor Maria Victoria Barbado González

Maria Victoria Barbado González has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20200281897
    Abstract: The invention relates to the use of a series of indazole compounds and the derivatives thereof in the production of a medicinal product to be administered alone or in combination with another suitable active ingredient in the treatment of cancer, and more specifically the treatment of hematological cancer.
    Type: Application
    Filed: April 27, 2017
    Publication date: September 10, 2020
    Inventors: José Antonio Pérez Simón, Maria Victoria Barbado González, Maite Medrano Domínguez, Nuria Eugenia Campillo Martín, Juan Antonio Páez Prosper, Pedro José González Naranjo
  • Publication number: 20180353461
    Abstract: A ceramide-generating anticancer agent or treatment, and/or a ceramide degradation inhibitor, or a pharmaceutically acceptable salt or ester thereof, for use in the prevention, treatment, or amelioration of cancer or tumors of the hematopoietic and lymphoid tissues.
    Type: Application
    Filed: December 4, 2015
    Publication date: December 13, 2018
    Inventors: José Antonio PÉREZ SIMÓN, María Victoria BARBADO GONZÁLEZ, María Teresa MEDRANO DOMÍNGUEZ
  • Patent number: 10045994
    Abstract: The present invention relates to the use of compounds of a cannabinoid nature for inhibiting viability with increasing doses of myeloma cell lines. Furthermore, said compounds have been shown not to affect CD34+ cells (normal hematopoietic progenitors) in terms of viability and proliferation. For this reason, the invention paves the way for the use of compounds of a cannabinoid nature as a promising therapy against multiple myeloma and related diseases.
    Type: Grant
    Filed: June 13, 2014
    Date of Patent: August 14, 2018
    Assignee: SERVICIO ANDALUZ DE SALUD
    Inventors: José Antonio Pérez Simón, María Victoria Barbado González
  • Publication number: 20160120874
    Abstract: The present invention relates to the use of compounds of a cannabinoid nature for inhibiting viability with increasing doses of myeloma cell lines. Furthermore, said compounds have been shown not to affect CD34+ cells (normal hematopoietic progenitors) in terms of viability and proliferation. For this reason, the invention paves the way for the use of compounds of a cannabinoid nature as a promising therapy against multiple myeloma and related diseases.
    Type: Application
    Filed: June 13, 2014
    Publication date: May 5, 2016
    Inventors: José Antonio Pérez Simón, María Victoria Barbado González